Skip to main content
Caplight Logo









Beijing Echo Biotech Co., Ltd.

Beijing Echo Biotech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://echobiotech.com

Last Round

Series B

Nov 6, 2025

Total Funding Raised

$38.71M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Beijing Echo Biotech Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Series B round in November 2025.

Beijing Echo Biotech Co., Ltd. is a biotechnology company that provides exosome-related research services, GMP-grade exosome raw materials, and engineered exosome technology platforms for regenerative medicine and disease treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service, Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Beijing Echo Biotech Co., Ltd. Comparables

Compare Beijing Echo Biotech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Echo Biotech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carrier Biomed (Suzhou) Co., Ltd.
85%
EXO Biologics
80%
CellBio Scientific
77%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Beijing Echo Biotech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 6, 2025
Series A ExtensionMar 3, 2023
Series A ExtensionJan 11, 2022
Series AJul 30, 2021
Pre SeedMar 25, 2019
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Guanyi Kong

CEO

Executive Team

For institutional investors. Book with your work email.

Beijing Echo Biotech Co., Ltd. Investors

Notable investors and investment history

Beijing Echo Biotech Co., Ltd. investors
InvestorRounds
Zhongbo JuliSeries A Extension, Series B
Baidu VenturesSeries A Extension
Ennovation VenturesPre Seed
Volcanics VentureSeries A, Series A Extension
Beihang Investment Co., Ltd.Series A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Grew 71% QoQ, from 7 to 12 employees.

  • Jun 25, 2026

    Grew 71% QoQ, from 7 to 12 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

Beijing Echo Biotech Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beijing Echo Biotech Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Beijing Echo Biotech Co., Ltd.'s valuation, stock price, and market status.

Is Beijing Echo Biotech Co., Ltd. a public or private company?

Beijing Echo Biotech Co., Ltd. is a private company.

What is the current stock price of Beijing Echo Biotech Co., Ltd.?

Beijing Echo Biotech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Echo Biotech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Beijing Echo Biotech Co., Ltd. worth (valuation)?

Valuation information for Beijing Echo Biotech Co., Ltd. is not publicly available.

Can I buy Beijing Echo Biotech Co., Ltd. stock?

Beijing Echo Biotech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Beijing Echo Biotech Co., Ltd.'s last funding round?

Beijing Echo Biotech Co., Ltd.'s most recent funding round was Series B on November 6, 2025.

Who are the main investors in Beijing Echo Biotech Co., Ltd.?

Key investors in Beijing Echo Biotech Co., Ltd. include Zhongbo Juli, Baidu Ventures.

Will Beijing Echo Biotech Co., Ltd. IPO soon?

No public IPO plans have been announced for Beijing Echo Biotech Co., Ltd..

How can I track Beijing Echo Biotech Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Beijing Echo Biotech Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range12
Year FoundedN/A
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?